Verweij, L.
Jepma, P.
Buurman, B. M.
Latour, C. H. M.
Engelbert, R. H. H.
ter Riet, G.
Karapinar-Çarkit, F.
Daliri, S.
Peters, R. J. G.
Scholte op Reimer, W. J. M.
Funding for this research was provided by:
ZonMw (520002002)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (023.008.024, 023.009.036)
Article History
Received: 5 March 2018
Accepted: 15 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: The CCB program has been approved by the Medical Ethics Committee of the AMC in the Netherlands (Protocol ID: MEC2016_024). Any relevant adjustments to the study protocol will be communicated to the Medical Ethics Committee of the AMC and to the Netherlands Trial Register. The study will be conducted in accordance with the Dutch Medical Research Involving Human Subjects and the WMA Declaration of Helsinki (1964). All patients will provide written informed consent before the start of the study. Netherlands Trial Register number: NTR6316, version 1 April 6th 2017.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.